Trial NCT02627677

View at ClinicalTrials.gov 
Org. Study IDs: AP24534-15-303
Secondary IDs: 2015-001318-92

Last trial update was posted on 2021-11-26

MeSH Interventions

Nilotinib Ponatinib

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Leukemia, Myeloid, Chronic-Phase

Other Conditions

Chronic Phase Chronic Myeloid Leukemia

Stopping Reasons

The study was stopped due to operational feasibility and not due to any safety concerns

Limitations And Caveats

This study was terminated due to operational feasibility and not due to any safety concerns.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID